Bull
$7.70
Szenariopreis
$0.830
-0.013 (-1.52%)Zum Schluss
Nano-X Imaging Ltd is an Israel-based company that develops a digital X-ray source enabling a cost reduction of imaging systems.
Given the current price of $0.8296 and the RSI at 26.389 indicating oversold conditions, the stock may seem attractive. However, with a staggering year-to-date change of -70.69% and a recent downgrade from analysts reflecting concerns over revenue visibility, it is advisable to sell. The main risk is the company's negative cash flow and widening net losses, with a reported net loss of $14.3 million in Q1 2026, raising significant concerns about its operational sustainability.
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Nano-X Investors Class Action Reminder

Nano-X Investors Reminded of Class Action Deadline

Faruqi & Faruqi Investigates Nano-X Investor Losses

Nano-X Class Action Reminder for Investors

Class Action Filed Against Nano-X Imaging Ltd. Over Securities Violations
Nano-X Imaging Ltd is an Israel-based company that develops a digital X-ray source enabling a cost reduction of imaging systems. It operates in the Healthcare sector (X- RAY APPARATUS AND TUBES AND RELATED IRRADIATION industry).
Given the current price of $0.8296 and the RSI at 26.389 indicating oversold conditions, the stock may seem attractive. However, with a staggering year-to-date change of -70.69% and a recent downgrade from analysts reflecting concerns over revenue visibility, it is advisable to sell. The main risk is the company's negative cash flow and widening net losses, with a reported net loss of $14.3 million in Q1 2026, raising significant concerns about its operational sustainability.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.